EA200500095A1 - Производные 4-(7-гало-2-хино(кса-)линилокси)феноксипропионовой кислоты в качестве противоопухолевых средств - Google Patents

Производные 4-(7-гало-2-хино(кса-)линилокси)феноксипропионовой кислоты в качестве противоопухолевых средств

Info

Publication number
EA200500095A1
EA200500095A1 EA200500095A EA200500095A EA200500095A1 EA 200500095 A1 EA200500095 A1 EA 200500095A1 EA 200500095 A EA200500095 A EA 200500095A EA 200500095 A EA200500095 A EA 200500095A EA 200500095 A1 EA200500095 A1 EA 200500095A1
Authority
EA
Eurasian Patent Office
Prior art keywords
linoiloxy
galo
ksa
hino
derivatives
Prior art date
Application number
EA200500095A
Other languages
English (en)
Other versions
EA009679B1 (ru
Inventor
Джером П. Хорвитц
Томас Х. Корбетт
Эдуардо Паломино
Лиза Полин
Стюарт Т. Хейзелдайн
Original Assignee
Вейне Стейт Юниверсити
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вейне Стейт Юниверсити filed Critical Вейне Стейт Юниверсити
Publication of EA200500095A1 publication Critical patent/EA200500095A1/ru
Publication of EA009679B1 publication Critical patent/EA009679B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)

Abstract

Изобретение касается соединений формулы (I), где A, X, Y и Z имеют значения, изложенные в описании. Эти соединения являются эффективными противоопухолевыми средствами. Изобретение также касается фармацевтических композиций, включающих соединение вышеуказанной формулы или его соль, промежуточных химических соединений, пригодных для получения соединения вышеуказанной формулы, и терапевтических способов, включающих введение соединения вышеуказанной формулы или его соли млекопитающему, нуждающемуся в такой терапии.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200500095A 2002-07-03 2003-07-03 Производные 4-(7-гало-2-хино(кса-)линилокси)феноксипропионовой кислоты в качестве противоопухолевых средств EA009679B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39385802P 2002-07-03 2002-07-03
PCT/US2003/021062 WO2004005260A1 (en) 2002-07-03 2003-07-03 A-`7-halo-2-quino (xa-) linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents

Publications (2)

Publication Number Publication Date
EA200500095A1 true EA200500095A1 (ru) 2005-06-30
EA009679B1 EA009679B1 (ru) 2008-02-28

Family

ID=30115656

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200500095A EA009679B1 (ru) 2002-07-03 2003-07-03 Производные 4-(7-гало-2-хино(кса-)линилокси)феноксипропионовой кислоты в качестве противоопухолевых средств

Country Status (18)

Country Link
US (3) US7109341B2 (ru)
EP (1) EP1539699A1 (ru)
JP (1) JP2005532397A (ru)
CN (1) CN1688547A (ru)
AU (2) AU2003249704B2 (ru)
BR (1) BR0311491A (ru)
CA (1) CA2491612C (ru)
EA (1) EA009679B1 (ru)
GE (1) GEP20074058B (ru)
IL (1) IL164555A0 (ru)
MX (1) MXPA05000233A (ru)
NO (1) NO20050573L (ru)
NZ (1) NZ535887A (ru)
PL (1) PL373624A1 (ru)
SG (1) SG145570A1 (ru)
UA (1) UA79293C2 (ru)
WO (2) WO2004005260A1 (ru)
ZA (1) ZA200408191B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1412332E (pt) * 2001-07-31 2005-06-30 Jerome P Horwitz Derivados de quinolina e sua utilizacao como agentes antitumorais
UA79293C2 (en) * 2002-07-03 2007-06-11 Univ Wayne State 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
KR20050038632A (ko) * 2002-08-24 2005-04-27 젠타리스 게엠베하 양성 및 악성 종양 질환의 치료를 위한 디스오라졸 및 이의유도체를 함유하는 의약
CN100427482C (zh) * 2005-08-01 2008-10-22 复旦大学 N,n-二甲胺酰基-2,3-二呋喃基-6-氨基喹噁啉,其制备方法与应用
US7470788B2 (en) * 2005-09-07 2008-12-30 Wayne State University Antitumor agents
US20070054938A1 (en) * 2005-09-07 2007-03-08 Horwitz Jerome P Antitumor agents
US8183379B2 (en) * 2005-09-07 2012-05-22 Wayne State University Antitumor agents
EP1897542A1 (en) * 2006-09-07 2008-03-12 Sanofi-Aventis Aqueous formulation comprising an antitumor agent
AU2008251557B2 (en) * 2007-05-10 2012-12-06 Albany Molecular Research, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
WO2011079305A1 (en) * 2009-12-23 2011-06-30 Wayne State University Therapeutic compounds
CN103127112A (zh) * 2013-02-27 2013-06-05 江苏先声药物研究有限公司 一类喹啉酮衍生物在肿瘤治疗中的应用
CN105085506B (zh) * 2014-05-16 2018-01-19 湖南大学 2‑[4‑(苯并噁唑‑2‑氧基)苯氧基]脂肪酰吡啶胺的医药用途
CN105085480B (zh) * 2014-05-16 2017-12-29 湖南大学 2‑[4‑（喹喔啉‑2‑氧基）苯氧基]脂肪酰吡啶胺的医药用途
CN107827828B (zh) * 2017-11-21 2021-03-30 南京华漫新材料科技有限公司 含苯酰肼骨架的喹喔啉衍生物及其制备方法和在制备抗肿瘤药物中的应用
CN110698418B (zh) * 2019-09-11 2022-07-01 广西师范大学 一种3-芳胺基喹喔啉-2-甲酰胺类衍生物及其制备方法和应用
TWI826034B (zh) * 2022-10-07 2023-12-11 宏碁股份有限公司 影像過曝改善方法及電子裝置

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54112628A (en) 1978-02-23 1979-09-03 Canon Inc Electromagnetic driving device
JPS6033389B2 (ja) * 1979-02-22 1985-08-02 日産化学工業株式会社 複素環エ−テル系フェノシキ脂肪酸誘導体、その製造法および該誘導体を含有する除草剤
US6197728B1 (en) * 1980-08-06 2001-03-06 Nissan Chemical Industries Ltd. Quinoxaline derivatives and herbicidal composition
US5364831A (en) * 1980-08-06 1994-11-15 Nissan Chemical Industries Ltd. Quinoxaline derivatives and herbicidal composition
US4760066A (en) * 1982-09-21 1988-07-26 Wayne State University Method for treating human tumor cell metastasis
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
PT79699B (en) 1983-12-22 1986-12-10 Pfizer Process for preparing quinolone inotropic agents
US5250690A (en) * 1985-05-02 1993-10-05 Dowelanco Haloalkoxy anilide derivatives of 2-4(-heterocyclic oxyphenoxy)alkanoic or alkenoic acids and their use as herbicides
JPS62190172A (ja) * 1986-02-14 1987-08-20 Teijin Ltd フエノキシ脂肪族カルボン酸誘導体および除草剤
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
AU5686794A (en) * 1992-12-15 1994-07-04 Du Pont Merck Pharmaceutical Company, The (2-quinoxalinyloxy)phenoxypropanoic acids and related derivatives as anticancer agents
EP0932601A4 (en) * 1996-08-30 2000-02-02 Lilly Co Eli METHOD FOR PRODUCING PHARMACEUTICALS
US6680311B1 (en) * 1996-08-30 2004-01-20 Eli Lilly And Company Cryptophycin compounds
BR9712805A (pt) * 1996-09-06 1999-11-23 Lilly Co Eli Processo para a preparação de compostos farmecêuticos
US6160006A (en) * 1996-10-18 2000-12-12 Wayne State University 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor in grapefruit
US6352991B1 (en) * 1997-01-08 2002-03-05 Wayne State University 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents
US6238644B1 (en) * 1997-09-03 2001-05-29 Wayne State University Method for treating and/or imaging breast cancer using radioactive iodide
US6586461B1 (en) * 1998-06-16 2003-07-01 Wayne State University Prenyl transferase inhibitors
US6103913A (en) * 1998-10-16 2000-08-15 Eli Lilly And Company Process for preparing enollactone derivatives
DE60114022T2 (de) * 2000-05-30 2006-07-13 Board Of Governors Of Wayne State University, Detroit Matrix metalloproteinase-inhibitoren
US6747021B2 (en) * 2000-10-02 2004-06-08 Eli Lilly And Company Cryptophycin compound
PT1412332E (pt) * 2001-07-31 2005-06-30 Jerome P Horwitz Derivados de quinolina e sua utilizacao como agentes antitumorais
UA79293C2 (en) 2002-07-03 2007-06-11 Univ Wayne State 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents

Also Published As

Publication number Publication date
BR0311491A (pt) 2005-04-26
AU2003249704B2 (en) 2010-05-20
UA79293C2 (en) 2007-06-11
CN1688547A (zh) 2005-10-26
IL164555A0 (en) 2005-12-18
US7728007B2 (en) 2010-06-01
SG145570A1 (en) 2008-09-29
US7109341B2 (en) 2006-09-19
AU2003249704A1 (en) 2004-01-23
US7585863B2 (en) 2009-09-08
EP1539699A1 (en) 2005-06-15
WO2004004651A2 (en) 2004-01-15
NZ535887A (en) 2006-11-30
US20090076073A1 (en) 2009-03-19
AU2003249722A1 (en) 2004-01-23
JP2005532397A (ja) 2005-10-27
CA2491612C (en) 2012-01-03
MXPA05000233A (es) 2005-04-11
ZA200408191B (en) 2006-07-26
NO20050573L (no) 2005-02-02
CA2491612A1 (en) 2004-01-15
US20040132618A1 (en) 2004-07-08
PL373624A1 (en) 2005-09-05
GEP20074058B (en) 2007-03-12
WO2004005260A1 (en) 2004-01-15
US20060293333A1 (en) 2006-12-28
EA009679B1 (ru) 2008-02-28

Similar Documents

Publication Publication Date Title
NO20050573L (no) 4-'7-halo-2-quino (XA) linyloksy ! fenoksypropionsyrederivater som antineoplastiske midler
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
EA200500814A1 (ru) Производные пирролопиримидина
EA200400606A1 (ru) ИНГИБИТОРЫ ФАКТОРА Ха И ДРУГИХ СЕРИНОВЫХ ПРОТЕАЗ, ВОВЛЕЧЁННЫХ В КОАГУЛЯЦИОННЫЙ КАСКАД
EA200500312A1 (ru) Новые спироконденсированные хиназолиноны и их применение в качестве ингибиторов фосфодиэстераз
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
EA200700099A1 (ru) Производные пиридина
SE0301373D0 (sv) Novel compounds
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
EA200500174A1 (ru) Новые производные бензимидазола, полезные в качестве антипролиферативных агентов
NO20060664L (no) N-substituerte benzimidazolyl C-kit inhibitorer
EA200600892A1 (ru) Новые хинолиновые производные
NO20076425L (no) Fremgangsmater for behandling av drug-resistent cancer
EA200500377A1 (ru) Пиразольные производные как ингибиторы трансформирующего фактора роста (tgf)
RU2006130686A (ru) Новые пиперидины в качестве модуляторов хемокинов (ccr)
DE602005022284D1 (de) Substituierte benzimidazole und deren verwendung zur induktion von apoptose
NO20082077L (no) Spirosykliske quinazolinderivater som PDE7-inhibitorer
ATE543803T1 (de) 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren
EA200702375A1 (ru) Производные мочевины, способы их получения и применения
SE0302116D0 (sv) Novel compounds
NO20050270L (no) Nye forbindelser, deres anvendelse og fremstilling
CY1111574T1 (el) Παραγωγα βουτανοϊκου οξεος, διαδικασιες για την παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιλαμβανουν και θεραπευτικες εφαρμογες αυτων
ATE390923T1 (de) Topoisomerase-giftmittel
EA200400219A1 (ru) Производные хинолина и их использование в качестве противоопухолевых средств

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU